However, in the study by Nakaji [43], which investigated the prognostic significance of the BRAF V600E mutation and MSI in sporadic CRC, there were no survival differences in the MSI-H group between the BRAF V600E mutation and BRAF wild-type groups (p = 0.4655). The gene discussed is BRAF; the disease is colorectal carcinoma.